Language

Medicine shortages: Belgium · Page 4

Official notices covering supply interruptions, limited availability and resumed supply. Each notice identifies the product, active ingredient, status and reported period.

Data checked:

1530 notices · Page 4 / 31

← Europe overview

National authority sources: Belgium

Recorded notices include resolved cases. The data check date differs from the modification date of an individual authority notice.

Medicine shortages: Belgium · Page 4

Belgium

Wellvone 750 mg/5 ml or. susp. 226 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Atovaquone

Notice details →
Belgium

Xarelto 1 mg/ml or. susp. (gran.) 5.25 g

Nicht verfügbar · Manufacturing delay
Active ingredient: Rivaroxaban

Notice details →
Belgium

Zoledronate EG 5 mg/100 ml inf. sol. i.v. vial 100 ml

Nicht verfügbar · Increased demand
Active ingredient: Zoledronic Acid

Notice details →
Belgium

Halcion 0.25 mg tabl. 250 UD

Marketing ended · Commercial reasons
Active ingredient: Triazolam

Notice details →
Belgium

Pregabalin Sandoz 75 mg hard caps. 14

Marketing ended · Commercial reasons
Active ingredient: Pregabalin

Notice details →
Belgium

Risperidon Sandoz 2 mg film-coat. tabl. 20

Marketing ended · Commercial reasons
Active ingredient: Risperidone

Notice details →
Belgium

Ventolin 1 mg/ml inf. sol. (conc.) i.v. amp. 5 ml

Marketing ended · Ersatz durch ein anderes Arzneimittel/eine andere Packung
Active ingredient: Salbutamol

Notice details →
Belgium

Acidcare 10 mg hard gastro-resist. caps. 28

Available again · Not specified
Active ingredient: Omeprazole

Notice details →
Belgium

Acidcare 20 mg hard gastro-resist. caps. 14

Available again · Not specified
Active ingredient: Omeprazole

Notice details →
Belgium

Aleve 220 mg film-coat. tabl. 24

Available again · Not specified
Active ingredient: Naproxen Sodium

Notice details →
Belgium

Alitretinoin Orifarm 30 mg soft caps. 30

Nicht verfügbar · Sonstige
Active ingredient: Alitretinoin

Notice details →
Belgium

Asaflow 80 mg gastro-resist. tabl. 56 (56 x 1) UD

Nicht verfügbar · Delay in final product release
Active ingredient: Acetylsalicylic Acid

Notice details →
Belgium

Azacitidin Sandoz 25 mg/ml inj. susp. (pwdr.) s.c. vial 100 mg

Marketing ended · Commercial reasons
Active ingredient: Azacitidine

Notice details →
Belgium

Bisoprolol Teva 2.5 mg tabl. 100

Nicht verfügbar · Manufacturing delay
Active ingredient: Bisoprolol Fumarate

Notice details →
Belgium

Brukinsa 80 mg hard caps. 120

Marketing ended · Ersatz durch ein anderes Arzneimittel/eine andere Packung
Active ingredient: Zanubrutinib

Notice details →
Belgium

Calci-Chew 500 mg chewable tabl. 120

Nicht verfügbar · Delay in final product release
Active ingredient: Calcium

Notice details →
Belgium

Ceftriaxone Fresenius Kabi 1 g inj./inf. sol. (pwdr.) i.m./i.v. vial 10 x 1 g

Nicht verfügbar · Manufacturing delay
Active ingredient: Ceftriaxone

Notice details →
Belgium

Clexane 15 000 IU (150 mg)/1 ml inj. sol. i.v./s.c. pre-filled syr. 10 x 1 ml UD

Nicht verfügbar · Sonstige
Active ingredient: Enoxaparin Sodium

Notice details →
Belgium

Dimethyl Fumarate Eurogenerics 240 mg hard gastro-resist. caps. 168

Marketing ended · Ersatz durch ein anderes Arzneimittel/eine andere Packung
Active ingredient: Dimethyl Fumarate

Notice details →
Belgium

Donepezil Sandoz 10 mg film-coat. tabl. 98

Nicht verfügbar · Increased demand
Active ingredient: Donepezil Hydrochloride

Notice details →
Belgium

Drovelis 3 mg - 14.2 mg film-coat. tabl. 13 x 28 (24 + 4)

Nicht verfügbar · Logistikprobleme (Transport, Zoll usw.)
Active ingredient: Drospirenone,Estetrol ,Placebo

Notice details →
Belgium

Dualkopt 20 mg/ml - 5 mg/ml eye drops sol. dropper cont. 10 ml

Available again · Not specified
Active ingredient: Timolol,Dorzolamide

Notice details →
Belgium

Erwinase 10 000 U inj./inf. sol. (pwdr.) i.m./i.v. vial 5 x 10000 U

Marketing ended · Active ingredient not available
Active ingredient: Crisantaspase

Notice details →
Belgium

Fostimon 75 IU inj. sol. (pwdr. + solv.) i.m./s.c. vial + amp. 75 IU + 1 ml

Marketing ended · Commercial reasons
Active ingredient: Urofollitropin

Notice details →
Belgium

Ganirelix Gedeon Richter 0.25 mg/0.5 ml inj. sol. s.c. pre-filled syr. 6 x 0.5 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Ganirelix

Notice details →
Belgium

Gliclazide Sandoz 60 mg tabl. modif.-rel. 180

Nicht verfügbar · Increased demand
Active ingredient: Gliclazide

Notice details →
Belgium

Imovane 7.5 mg (PI Pharma) film-coat. tabl. 30

Nicht verfügbar · Sonstige
Active ingredient: Zopiclone

Notice details →
Belgium

Legalon (Impexeco) hard caps. 60

Nicht verfügbar · Sonstige
Active ingredient: Silymarin (DNPH)

Notice details →
Belgium

Lenzetto 1.53 mg/dose transderm. spray sol. met. pump 6.5 ml (56 doses)

Nicht verfügbar · Logistikprobleme (Transport, Zoll usw.)
Active ingredient: Estradiol

Notice details →
Belgium

Letrozole EG 2.5 mg (PI Pharma) film-coat. tabl. 100

Nicht verfügbar · Sonstige
Active ingredient: Letrozole

Notice details →
Belgium

Lindynette 30 75 µg - 30 µg coat. tabl. 6 x 21

Nicht verfügbar · Logistikprobleme (Transport, Zoll usw.)
Active ingredient: Ethinylestradiol,Gestodene

Notice details →
Belgium

Losartan Plus EG 100 mg - 12.5 mg film-coat. tabl. 98

Nicht verfügbar · Manufacturing delay
Active ingredient: Hydrochlorothiazide,Losartan

Notice details →
Belgium

Metformine Sandoz 500 mg film-coat. tabl. 60

Available again · Not specified
Active ingredient: Metformin

Notice details →
Belgium

Metformine Sandoz 850 mg film-coat. tabl. 100

Nicht verfügbar · Manufacturing delay
Active ingredient: Metformin

Notice details →
Belgium

Methotrexate Accord Healthcare 25 mg/ml inj. sol. i.m./i.thec./i.v./i.arter. vial 2 ml

Nicht verfügbar · Increased demand
Active ingredient: Methotrexate

Notice details →
Belgium

Mictonorm Forte 45 mg (PI Pharma) hard caps. prol.-rel. 84

Nicht verfügbar · Sonstige
Active ingredient: Propiverine

Notice details →
Belgium

Mirtazapine Sandoz 45 mg orodisp. tabl. 100

Nicht verfügbar · Increased demand
Active ingredient: Mirtazapine

Notice details →
Belgium

Montelukast Sandoz 10 mg (Impexeco) film-coat. tabl. 98

Nicht verfügbar · Sonstige
Active ingredient: Montelukast

Notice details →
Belgium

Myrosor 10 mg - 10 mg (PI Pharma) film-coat. tabl. 90

Nicht verfügbar · Sonstige
Active ingredient: Ezetimibe ,Rosuvastatin

Notice details →
Belgium

Naropin 5 mg/ml inj. sol. i.thec. amp. 5 x 10 ml

Nicht verfügbar · Increased demand
Active ingredient: Ropivacaine Hydrochloride

Notice details →
Belgium

Neurontin 600 mg (PI Pharma) film-coat. tabl. 90

Nicht verfügbar · Sonstige
Active ingredient: Gabapentin

Notice details →
Belgium

Nexviadyme 100 mg inj. sol. (pwdr., conc.) i.v. vial 100 mg

Nicht verfügbar · Delay in final product release
Active ingredient: Avalglucosidase Alfa

Notice details →
Belgium

Pantoprazole Kalceks 40 mg inj. sol. (pwdr.) i.v. vial 10 x 10 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Pantoprazole

Notice details →
Belgium

Paracetamol Sandoz 1 g efferv. tabl. 32

Available again · Not specified
Active ingredient: Paracetamol

Notice details →
Belgium

Pneumovax 23 inj. sol. s.c./i.m. pre-filled syr. 1 dose (0.5 ml)

Marketing ended · Commercial reasons
Active ingredient: Pneumococcal Polysaccharide Vaccine

Notice details →
Belgium

Pramipexol Retard Sandoz 2.1 mg tabl. prol.-rel. 100

Available again · Not specified
Active ingredient: Pramipexole

Notice details →
Belgium

Pramipexole Teva 0.18 mg tabl. 100 (100 x 1) UD

Nicht verfügbar · Increased demand
Active ingredient: Pramipexole

Notice details →
Belgium

Pregabalin Sandoz 150 mg hard caps. 210 (210 x 1) UD

Available again · Not specified
Active ingredient: Pregabalin

Notice details →
Belgium

Quetiapine Retard Teva 50 mg tabl. prol.-rel. 60

Available again · Not specified
Active ingredient: Quetiapine

Notice details →
Belgium

R Calm 20 mg/g cut. emuls. 90 ml

Available again · Not specified
Active ingredient: Diphenhydramine Hydrochloride

Notice details →